Page last updated: 2024-11-04

sulfamethoxypyridazine and Benign Mucosal Pemphigoid

sulfamethoxypyridazine has been researched along with Benign Mucosal Pemphigoid in 2 studies

Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"One-hundred and sixty-eight cases of dermatitis herpetiformis were reviewed to compare the clinical response to and incidence of side-effects from dapsone and sulphamethoxypyridazine."3.67Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid. ( Fry, L; Leonard, JN; McFadden, JP; Powles, AV; Rutman, AJ, 1989)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thornhill, M1
Pemberton, M1
Buchanan, J1
Theaker, E1
McFadden, JP1
Leonard, JN1
Powles, AV1
Rutman, AJ1
Fry, L1

Trials

1 trial available for sulfamethoxypyridazine and Benign Mucosal Pemphigoid

ArticleYear
An open clinical trial of sulphamethoxypyridazine in the treatment of mucous membrane pemphigoid.
    The British journal of dermatology, 2000, Volume: 143, Issue:1

    Topics: Aged; Anti-Infective Agents; Drug Hypersensitivity; Female; Hemolysis; Humans; Male; Middle Aged; Mo

2000

Other Studies

1 other study available for sulfamethoxypyridazine and Benign Mucosal Pemphigoid

ArticleYear
Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid.
    The British journal of dermatology, 1989, Volume: 121, Issue:6

    Topics: Adolescent; Adult; Aged; Dapsone; Dermatitis Herpetiformis; Drug Evaluation; Female; Humans; Immunog

1989